8 documents found, page 1 of 1
The HepHIV 2023 Madrid conference: A call to action for political leadership in...
Simões, D; Raben, D; Moran, AB; Imaz, A; Stengaard, AR; Raahauge, A; Sullivan, AK; Vaughan, E; Brännström, J; De Baetselier, I; Platteau, T; Casabona, JIntroduction and Objectives: The HepHIV 2023 Conference, held in Madrid in November 2023, highlighted how Europe is not on track to meet the United Nations (UN) sustainable development goals and Joint UN Programme on HIV/AIDS (UNAIDS) targets. This article presents the outcomes of the conference, which focus on ways to improve testing and linkage to care for HIV, viral hepatitis, and other sexually transmitted ...
Late diagnosis of HIV: An updated consensus definition
Croxford, S; Stengaard, AR; Brännström, J; Combs, L; Dedes, N; Girardi, E; Grabar, S; Kirk, O; Kuchukhidze, G; Lazarus, JV; Noori, T; Pharris, AIntroduction: In recent years, HIV testing frequency has increased, resulting in more people being diagnosed during seroconversion with a temporarily low CD4 count. Using the current consensus definition of late HIV presentation ('presenting for care with a CD4 count < 350 cells/μL or an AIDS-defining event, regardless of CD4 count') these individuals would be incorrectly assigned as being diagnosed late. Metho...
A call to action to reclaim focus on testing and early treatment for HIV, viral...
Stengaard, AR; Raben, D; Leite, RB; Seyler, T; Lazarus, JV; Lambert, J; Collins, B; Attawell, K; Raahauge, A; Rockstroh, JK; Simões, DWe present the outcomes of the HepHIV 2021 Lisbon & virtual conference held on 5-7 May 2021, including a Call to Action addressing policy and practice implications in the field of earlier and integrated testing for HIV, viral hepatitis, STI and TB and in light of lessons learned from the COVID-19 pandemic. Conference presentations showed that combination prevention and integrated testing and care models for mul...
HIV seroprevalence in five key populations in Europe: a systematic literature r...
Stengaard, AR; Combs, L; Supervie, V; Croxford, S; Desai, S; Sullivan, AK; Jakobsen, SF; Santos, Q; Simões, D; Casabona, J; Lazarus, JV; de Wit, JBFBackground: In Europe, HIV disproportionately affects men who have sex with men (MSM), people who inject drugs (PWID), prisoners, sex workers, and transgender people. Epidemiological data are primarily available from national HIV case surveillance systems that rarely capture information on sex work, gender identity or imprisonment. Surveillance of HIV prevalence in key populations often occurs as independent st...
Increasing integrated testing in community settings through interventions for c...
Gasbarrini, N; Dubravić, D; Combs, L; Dišković, A; Ankiersztejn-Bartczak, M; Colaiaco, F; Wawer, I; Wysocki, P; Rosińska, M; Marzec-Boguslawska, ABackground: Maximising access to testing by targeting more than one infection is effective in identifying new infections in settings or populations. Within the EU funded Joint Action INTEGRATE, this paper examined the feasibility and impact of expanding integrated testing for HIV, hepatitis C (HCV), chlamydia, gonorrhoea and/or syphilis in four community-based pilots through targeted interventions in Croatia, I...
The Association Between Hepatitis B Virus Infection and Nonliver Malignancies i...
Mocroft, A; Miro, J; Wandeler, G; Llibre, J; Boyd, A; van Bremen, K; Beniowski, M; Mikhalik, J; Cavassini, M; Maltez, F; Duvivier, C; Uberti Foppa, CObjectives: The aim of this study was to assess the impact of hepatitis B virus (HBV) infection on non-liver malignancies in people living with HIV (PLWH). Methods: All persons aged ≥ 18 years with known hepatitis B virus (HBV) surface antigen (HBsAg) status after the latest of 1 January 2001 and enrolment in the EuroSIDA cohort (baseline) were included in the study; persons were categorized as HBV positive or ...
A call to action toward integrated testing and earlier care for viral hepatitis...
Raben, D; Hoekstra, M; Combs, L; Sullivan, AK; Lazarus, JV; Lambert, JS; Simões, D; Streinu-Cercel, A; Rockstroh, JK; Streinu-Cercel, A; Amato-Gauci, AObjectives. The objective of the paper is to present the outcomes of the HepHIV 2019 conference, held in Bucharest under the Romanian EU Presidency and focusing on challenges of timely and integrated testing and care. Methods. The conference programme was put together by the organizing committee. It consisted of invited talks and peer-reviewed abstracts. Results. In all, 65 abstracts from 20 countries were pres...
Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis an...
Simões, D; Stengaard, AR; Combs, L; Raben, D; EuroTEST COVID-19 impact assessment consortium of partnersWe present preliminary results of a coronavirus disease (COVID-19) impact assessment on testing for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region. We analyse 98 responses from secondary care (n = 36), community testing sites (n = 52) and national level (n = 10). Compared to pre-COVID-19, 95% of respondents report decreased testing volumes during March–May and 58% during Jun...